86.0 A
DSIP
Also known as: Delta sleep-inducing peptide
Strong Clinical Evidence Research Chemical
Research Evidence 92.0/100
Safety Profile 80.0/100
48 Clinical Trials
Unknown: 3 PHASE4: 11 PHASE3: 7 PHASE2, PHASE3: 1 PHASE2: 9 PHASE1: 1 NA: 16
- VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study Unknown Phase RECRUITING Alimentiv Inc.
- A Real-world Study to Assess Safety and Effectiveness of Xolair® in Pediatric Chronic Spontaneous Urticaria in China Unknown Phase COMPLETED Novartis Pharmaceuticals
- Role of Hypoxia Ans Sleep Fragmentation in Alzheimer's Disease. and Sleep Fragmentation. Unknown Phase COMPLETED Sociedad Española de Neumología y Cirugía Torácica
- A Randomised Controlled Trial of N-acetylcysteine for the Management of Alcohol Use Disorder PHASE4 RECRUITING University of Sydney
- Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid Arthritis PHASE4 UNKNOWN Leiden University Medical Center
Showing 5 of 48 trials.
19 Research Papers
- Domain-specific information preservation for Alzheimer's disease diagnosis with incomplete multi-modality neuroimages. Med Image Anal unknown
- Phosphorylated delta sleep inducing peptide restores spatial memory and p-CREB expression by improving sleep architecture at high altitude. Life Sci unknown
- Ozone Therapy Protects Against Rejection in a Lung Transplantation Model: A New Treatment? Ann Thorac Surg unknown
- Expression and Purification of Delta Sleep-Inducing Peptide Fused with Protein Transduction Domain and Human Serum Albumin in Pichia pastoris. Protein Pept Lett unknown
- An RCT study on the feasibility of anterior transpedicular screw fixation in the cervicothoracic junction. Eur Spine J Human
Showing 5 of 19 papers by citation count.
FDA Data
Not FDA-Approved
DSIP has not been evaluated by the FDA for safety or efficacy. It is not approved for human therapeutic use in the United States.
Frequently Asked Questions
Is DSIP FDA approved?
No, DSIP has not been approved by the FDA for human therapeutic use. It is sold as a research chemical.
How many clinical trials has DSIP been studied in?
DSIP has been studied in 48 registered clinical trials. CheckPeptides tracks phase, status, and sponsor data for each trial.
What is the trust score for DSIP?
DSIP has a CheckPeptides trust score of 86.0/100 (grade: A). This score is based on clinical trial volume, research paper quality, FDA data, and evidence classification.
Last verified: April 7, 2026
Quick Facts
- Classification
- Neuropeptide
- Molecular Weight
- 848.8 Da
- PubChem
- CID 68816 ↗
- Regulatory Status
- N/A
Score Breakdown
Research Evidence 92.0/100
Safety Profile 80.0/100
Evidence Summary
- Clinical Trials
- 48
- Research Papers
- 19
- Trust Score
- 86.0/100
- Grade
- A